Over-the-counter drug · ANDA
Lansoprazole NDC 55111-739
Lansoprazole 15 mg/1 · Capsule, Delayed release · Oral · Dr. Reddy's Laboratories Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 55111-739-27 | 5511107392755111073927 | 2 BOTTLE in 1 CARTON (55111-739-27) / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLEMarketed from Aug 19, 2019 | |
| 55111-739-33 | 5511107393355111073933 | 3 BOTTLE in 1 CARTON (55111-739-33) / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLEMarketed from Aug 19, 2019 | |
| 55111-739-52 | 5511107395255111073952 | 1 BOTTLE in 1 CARTON (55111-739-52) / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLEMarketed from Aug 19, 2019 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Lansoprazole
- Generic name (nonproprietary)
- lansoprazole
- Active ingredients
- Lansoprazole — 15 mg/1
- Dosage form
- Capsule, Delayed release
- Route
- Oral
- Labeler
- Dr. Reddy's Laboratories LimitedNDC labeler code 55111
- Product type
- Over-the-counter drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 202194
- Marketing start
- Listing expires
- Other FDA classes
- Inhibition Gastric Acid Secretion (Physiologic effect)Proton Pump Inhibitors (Mechanism)
- Identifiers
- Product ID 55111-739_06355b28-9bb0-baea-0f4b-f1e4f7e670b6SPL ID 06355b28-9bb0-baea-0f4b-f1e4f7e670b6SPL set ID 15e05eda-48aa-a4b7-4b8a-4ee1cf110120RxCUI 596843UNII 0K5C5T2QPG
- Pharmacologic class
- Proton Pump Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N455111073927followed by a unit qualifier and the quantityPackage 55111-0739-27. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Use treats frequent heartburn (occurs 2 or more days a week) not intended for immediate relief of heartburn; this drug may take 1 to 4 days for full effect
Excerpt only. Read the full label for complete information.
About NDC 55111-739
- What is NDC 55111-739?
- 55111-739 is the product NDC for Lansoprazole, Lansoprazole 15 mg/1 capsule, delayed release, listed with the FDA by Dr. Reddy's Laboratories Limited. It has 3 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Lansoprazole.
- What is the active ingredient?
- Lansoprazole.
- Who is the labeler?
- Dr. Reddy's Laboratories Limited, NDC labeler code 55111. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Lansoprazole?
- 94 other product NDCs are listed under this name. See all Lansoprazole NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Lansoprazole products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Lansoprazole | Lansoprazole 30 mg/1 | Tablet, Orally disintegrating, Delayed releaseOral | Cardinal Health 107, LLC | 55154-8340 | 55154-8340-00 |
| Lansoprazole | Lansoprazole 30 mg/1 | Capsule, Delayed release pelletsOral | Preferred Pharmaceuticals Inc. | 68788-4141 | 68788-4141-0368788-4141-0668788-4141-09 |
| Lansoprazole | Lansoprazole 15 mg/1 | Tablet, Orally disintegrating, Delayed releaseOral | Amazon.com Services LLC | 72288-672 | 72288-0672-55 |
| Lansoprazole | Lansoprazole 15 mg/1 | Capsule, Delayed releaseOral | Amazon.com Services LLC | 72288-827 | 72288-0827-03 |
| Lansoprazole | Lansoprazole 30 mg/1 | Capsule, Delayed release pelletsOral | Safecor Health LLC | 48433-051 | 48433-0051-08 |
| Lansoprazole | Lansoprazole 30 mg/1 | Capsule, Delayed releaseOral | Medcore LLC | 82461-713 | 82461-0713-30 |
| Lansoprazole | Lansoprazole 15 mg/1 | Capsule, Delayed releaseOral | Macleods Pharmaceuticals Limited | 33342-310 | 33342-0310-07 |
| Lansoprazole | Lansoprazole 30 mg/1 | Capsule, Delayed releaseOral | Macleods Pharmaceuticals Limited | 33342-311 | 33342-0311-07 |
| Lansoprazole | Lansoprazole 30 mg/1 | Capsule, Delayed releaseOral | Preferred Pharmaceuticals Inc. | 68788-8621 | 68788-8621-0168788-8621-0368788-8621-06+2 more |
| Lansoprazole | Lansoprazole 15 mg/1 | Tablet, Orally disintegrating, Delayed releaseOral | Aurobindo Pharma Limited | 65862-895 | 65862-0895-78 |
Other NDCs under ANDA 202194
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Lansoprazole | Lansoprazole 15 mg/1 | Capsule, Delayed releaseOral | Walgreens company | 0363-0037 |
| Lansoprazole | Lansoprazole 15 mg/1 | Capsule, Delayed releaseOral | Rugby Laboratories, Inc | 0536-1368 |
| Lansoprazole | Lansoprazole 15 mg/1 | Capsule, Delayed releaseOral | Dr. Reddy's Laboratories Inc. | 43598-109 |
| Lansoprazole | Lansoprazole 15 mg/1 | Capsule, Delayed releaseOral | Dr. Reddy's Laboratories Inc. | 43598-161 |
| Lansoprazole | Lansoprazole 15 mg/1 | Capsule, Delayed releaseOral | AMERISOURCEBERGEN DRUG CORPORATION | 46122-744 |
| Lansoprazole | Lansoprazole 15 mg/1 | Capsule, Delayed releaseOral | LEADER/ Cardinal Health 110, Inc. | 70000-0612 |
| Lansoprazole | Lansoprazole 15 mg/1 | Capsule, Delayed releaseOral | Chain Drug Marketing Association | 83324-001 |